Literature DB >> 6805186

Tumourigenesis: the subterfuge of selection.

R D Pearson.   

Abstract

Variation of rearrangement of regulatory genes is responsible for cellular malignant change. These types of chromosomal variations also produce heterochrony or paedomorphic evolution at the organismal level. Analogously, neoplasia represents a cellular 'macroevolutionary' event, and a tumour can be said to be an evolved population of cells. To understand this cellular evolution to malignancy, it may be necessary to go beyond a 'clonal selection' (adaptationist) explanation of neoplastic alteration. In the pericellular environment 'natural selection' consists of the organizational restraints of surrounding cells as well as the host's immunological surveillance and non-specific monocyte-macrophage systems. Indirect evidence suggests that success for the neoplasm depends not upon 'clonal selection', but solely upon a genetic methodology-the function of which is to elude selection. The author has coined the term 'cellular heterochrony' to illustrate analogic similarities in the molecular modes of speciation between anaplastic cancer cells and the heterochronic evolution of organisms. By reverting to juvenile (embryonic) repertoire of cellular behaviour a tumour secures its own tenure or niche by usurping the host's armamentarium of selection forces, employing many of the same or similar methods by which implanting and invading tissues of the mammalian embryo forestall maternal detection and rejection. A number of ways by which the tumour blocks, subverts or evades selection are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6805186     DOI: 10.1007/BF00047008

Source DB:  PubMed          Journal:  Acta Biotheor        ISSN: 0001-5342            Impact factor:   1.774


  12 in total

1.  Non-Darwinian "evolution" and biological progress.

Authors:  J M Thoday
Journal:  Nature       Date:  1975-06-26       Impact factor: 49.962

Review 2.  Retrodifferentiation and the fetal patterns of gene expression in cancer.

Authors:  J Uriel
Journal:  Adv Cancer Res       Date:  1979       Impact factor: 6.242

Review 3.  Cancer: somatic-genetic considerations.

Authors:  F M Burnet
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

4.  Clinical and pharmacological implications of cancer cell differentiation and heterogeneity.

Authors:  P Calabresi; D L Dexter; G H Heppner
Journal:  Biochem Pharmacol       Date:  1979-06-15       Impact factor: 5.858

5.  Biological evolution: natural selection or random walk?

Authors:  F J Ayala
Journal:  Am Sci       Date:  1974 Nov-Dec       Impact factor: 0.548

6.  Gene regulation for higher cells: a theory.

Authors:  R J Britten; E H Davidson
Journal:  Science       Date:  1969-07-25       Impact factor: 47.728

7.  Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products.

Authors:  H F Dvorak; N S Orenstein; A C Carvalho; W H Churchill; A M Dvorak; S J Galli; J Feder; A M Bitzer; J Rypysc; P Giovinco
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

8.  The neutral theory of molecular evolution.

Authors:  M Kimura
Journal:  Sci Am       Date:  1979-11       Impact factor: 2.142

9.  The reversibility of cancer: the relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1.

Authors:  D F Horrobin
Journal:  Med Hypotheses       Date:  1980-05       Impact factor: 1.538

10.  Maturation-induction of tumor cells using a human colon carcinoma model.

Authors:  D L Dexter; J C Hager
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.